Skip to main content
OpenTrials

Clinical trial condition

Carbohydrate Metabolism, Inborn Errors

Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

551 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Carbohydrate Metabolism, Inborn Errors trial results

Completed

A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients

NCT00144768

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • Childrens Hospital Los Angeles Los Angles, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Observational Study of Patients With Mucopolysaccharidosis (MPS) VI Who Previously Participated in ASB-00-02

NCT01387854

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Children's Hospital and Research Center Oakland, California, United States
  • Women's and Children's hospital North Adelaide, Australia
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
  • Hôpital Femme Mère Enfant Lyon, France
View Trial Details
Completed

High Dose or High Dose Frequency Study of Alglucosidase Alfa

NCT00483379

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Birmingham, Alabama, United States
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Chicago, Illinois, United States
View Trial Details
Completed

Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease

NCT00074932

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Colorado Health Science Center Aurora, Colorado, United States
  • Galichia Heart Hospital Wichita, Kansas, United States
  • Genzyme Medical Information Cambridge, Massachusetts, United States
  • Freeman Health Systems Joplin, Missouri, United States
View Trial Details
Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

NCT00125879

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Shands Hospital at the University of Florida Gainesville, Florida, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Emory University Medical Genetics Decatur, Georgia, United States
View all 14 locations
View Trial Details

Related conditions